Cargando…

USP28: Oncogene or Tumor Suppressor? A Unifying Paradigm for Squamous Cell Carcinoma

Squamous cell carcinomas are therapeutically challenging tumor entities. Low response rates to radiotherapy and chemotherapy are commonly observed in squamous patients and, accordingly, the mortality rate is relatively high compared to other tumor entities. Recently, targeting USP28 has been emerged...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prieto-Garcia, Cristian, Tomašković, Ines, Shah, Varun Jayeshkumar, Dikic, Ivan, Diefenbacher, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534253/ https://www.ncbi.nlm.nih.gov/pubmed/34685632 http://dx.doi.org/10.3390/cells10102652

Ejemplares similares

Inhibition of USP28 overcomes Cisplatin-resistance of squamous tumors by suppression of the Fanconi anemia pathway
por: Prieto-Garcia, Cristian, et al.
Publicado: (2021)

USP28 enables oncogenic transformation of respiratory cells, and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K
por: Prieto‐Garcia, Cristian, et al.
Publicado: (2022)

Maintaining protein stability of ∆Np63 via USP28 is required by squamous cancer cells
por: Prieto‐Garcia, Cristian, et al.
Publicado: (2020)

USP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancer
por: Maier, Carina R., et al.
Publicado: (2023)

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma
por: Cao, Yu-Fei, et al.
Publicado: (2022)

Distinct USP25 and USP28 Oligomerization States Regulate Deubiquitinating Activity
por: Gersch, Malte, et al.
Publicado: (2019)

Targeting deubiquitinase USP28 for cancer therapy
por: Wang, Xiaofang, et al.
Publicado: (2018)

Fbw7 and Usp28 – enemies and allies
por: Taranets, Lyudmyla, et al.
Publicado: (2015)

Characterization of alternatively spliced products and tissue-specific isoforms of USP28 and USP25
por: Valero, Rebeca, et al.
Publicado: (2001)

USP13 serves as a tumor suppressor via the PTEN/AKT pathway in oral squamous cell carcinoma
por: Qu, Zhi, et al.
Publicado: (2019)

Oncogenes and tumor suppressor genes in squamous cell carcinoma of the tongue in young patients
por: Knopf, Andreas, et al.
Publicado: (2015)

Oxidative Stress: A Unifying Paradigm in Hypertension
por: Touyz, Rhian M., et al.
Publicado: (2020)

Minimized combinatorial CRISPR screens identify genetic interactions in autophagy
por: Diehl, Valentina, et al.
Publicado: (2021)

USP28 deletion and small-molecule inhibition destabilizes c-MYC and elicits regression of squamous cell lung carcinoma
por: Ruiz, E Josue, et al.
Publicado: (2021)

Stabilization of PIM Kinases in Hypoxia Is Mediated by the Deubiquitinase USP28
por: Toth, Rachel K., et al.
Publicado: (2022)

Usp5 functions as an oncogene for stimulating tumorigenesis in hepatocellular carcinoma
por: Liu, Yi, et al.
Publicado: (2017)

Tumor-Suppressor Genes and Oncogenes
Publicado: (1993)

Oncogenes and tumor-suppressor genes.
por: Lehman, T A, et al.
Publicado: (1991)

Unifying Catalysis Framework to Dissect Proteasomal Degradation Paradigms
por: Rodriguez-Rivera, Frances P., et al.
Publicado: (2021)

Up‐regulated deubiquitinase USP4 plays an oncogenic role in melanoma
por: Guo, Weinan, et al.
Publicado: (2018)

RUNX family: Oncogenes or tumor suppressors
por: Otálora-Otálora, Beatriz Andrea, et al.
Publicado: (2019)

BRAID: A Unifying Paradigm for the Analysis of Combined Drug Action
por: Twarog, Nathaniel R., et al.
Publicado: (2016)

USP17 is required for trafficking and oncogenic signaling of mutant EGFR in NSCLC cells
por: McCann, Aidan P., et al.
Publicado: (2018)

Tumor Suppressor LINC02487 Inhibits Oral Squamous Cell Carcinoma Cell Migration and Invasion Through the USP17–SNAI1 Axis
por: Feng, Lu, et al.
Publicado: (2020)

Erratum: BRAID: A Unifying Paradigm for the Analysis of Combined Drug Action
por: Twarog, Nathaniel R., et al.
Publicado: (2018)

Angiomotin Family Members: Oncogenes or Tumor Suppressors?
por: Lv, Meng, et al.
Publicado: (2017)

SIRT3: Oncogene and Tumor Suppressor in Cancer
por: Torrens-Mas, Margalida, et al.
Publicado: (2017)

Tuning of Alternative Splicing - Switch From Proto-Oncogene to Tumor Suppressor
por: Shchelkunova, Aleksandra, et al.
Publicado: (2012)

Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies
por: Saei, Azad, et al.
Publicado: (2018)

The deubiquitinase USP28 maintains the expression of the transcription factor MYCN and is essential in neuroblastoma cells
por: Li, Junjun, et al.
Publicado: (2023)

Deubiquitinating enzyme USP37 regulating oncogenic function of 14-3-3γ
por: Kim, Jin-Ock, et al.
Publicado: (2015)

USP21 deubiquitinase elevates macropinocytosis to enable oncogenic KRAS bypass in pancreatic cancer
por: Hou, Pingping, et al.
Publicado: (2021)

Comprehensive Analysis Reveals USP45 as a Novel Putative Oncogene in Pan-Cancer
por: Li, Kai, et al.
Publicado: (2022)

Phosphorylation of USP29 by CDK1 Governs TWIST1 Stability and Oncogenic Functions
por: Guan, Tangming, et al.
Publicado: (2023)

Paradigms in multiple sclerosis: time for a change, time for a unifying concept
por: Krone, Bernd, et al.
Publicado: (2011)

Oncogenes and tumor-suppressor genes in mesothelioma--a synopsis.
por: Lechner, J F, et al.
Publicado: (1997)

Genetic Basis for Carcinogenesis. Tumor Suppressor Genes and Oncogenes
por: Rabbitts, P.
Publicado: (1992)

Is miR-29 an oncogene or tumor suppressor in CLL?
por: Pekarsky, Yuri, et al.
Publicado: (2010)

IGF-Binding Protein 2 – Oncogene or Tumor Suppressor?
por: Pickard, Adam, et al.
Publicado: (2015)

RhoB: Team Oncogene or Team Tumor Suppressor?
por: Ju, Julia A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7heio20fhtglc2prg67r4itdpi